UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 219

Sortiert nach

Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient's plasma - a prospective trial

BMC cancer, 2021-09, Vol.21 (1), p.1037-8, Article 1037

2021

Volltextzugriff (PDF)

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Gynecologic oncology, 2013-10, Vol.131 (1), p.15-20

2013

Volltextzugriff (PDF)

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients – A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)

European journal of cancer (1990), 2014-08, Vol.50 (12), p.2090-2098

2014

Volltextzugriff (PDF)

Statistical controversies in clinical research: the importance of importance

Annals of oncology, 2016-07, Vol.27 (7), p.1185-1189

2016

Volltextzugriff (PDF)

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study

Gynecologic oncology, 2013-02, Vol.128 (2), p.245-251

2013

Volltextzugriff (PDF)

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

Annals of oncology, 2012-07, Vol.23 (7), p.1795-1802

2012

Volltextzugriff (PDF)

Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer

Oncogene, 2010-04, Vol.29 (13), p.1997-2004

2010

Volltextzugriff (PDF)

2775 Peritoneal cavity: The achilles' heel for ovarian cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S556-S556

2015

Volltextzugriff (PDF)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593-1599

2011

Volltextzugriff (PDF)

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593-1599

2011

Volltextzugriff (PDF)

In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity

Clinical cancer research, 1998-12, Vol.4 (12), p.2925-2929

1998

Volltextzugriff (PDF)

134 Correlation of circular RNA abundance with proliferation – exemplified with human normal, benign and malignant tissues

European journal of cancer (1990), 2015-09, Vol.51, p.S10-S10

2015

Volltextzugriff (PDF)

799: Role of cyclosporine A as chemomodulator of cisplatin cytotoxicity in ovarian cancer cell lines

European journal of cancer (1990), 2014-07, Vol.50, p.S193-S193

2014

Volltextzugriff (PDF)

eNOSI4 and EPHX1 polymorphisms affect maternal susceptibility to preeclampsia: analysis of five polymorphisms predisposing to cardiovascular disease in 279 Caucasian and 241 African women

Archives of gynecology and obstetrics, 2014-03, Vol.289 (3), p.581-593

2014

Volltextzugriff (PDF)

2777 Lavage of the uterine cavity for early and differential diagnosis of serous ovarian cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S557-S557

2015

Volltextzugriff (PDF)

454 Circulating rare cells enable highly efficient cancer detection

European journal of cancer (1990), 2015-09, Vol.51, p.S96-S96

2015

Volltextzugriff (PDF)

6P CHEMOTHERAPY-ENFORCED EXPRESSION OF CANCER STEM CELL MARKERS IN A SERIES OF THREE SCLC CELL LINES OBTAINED DURING CLINICAL TREATMENT

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S3-S3

2013

Volltextzugriff (PDF)

In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway

British journal of cancer, 2007-02, Vol.96 (3), p.485-491

2007

Volltextzugriff (PDF)

Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors : Definition of phenotypic groups

Cancer research (Chicago, Ill.), 1997-10, Vol.57 (19), p.4360-4367

1997

Volltextzugriff (PDF)

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients

Gynecologic oncology, 2013-02, Vol.128 (2), p.245-251

2013

Volltextzugriff (PDF)

Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain

PCR methods and applications, 1995-02, Vol.4 (4), p.234

1995

Volltextzugriff (PDF)

Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors

International journal of cancer, 1996-08, Vol.69 (4), p.247-253

1996

Volltextzugriff (PDF)

Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan

Cell reports (Cambridge), 2019-07, Vol.28 (1), p.132-144.e3

2019

Volltextzugriff (PDF)

Patient satisfaction after breast cancer surgery – a prospective clinical trial

Geburtshilfe und Frauenheilkunde, 2018, Vol.78 (5)

2018

Volltextzugriff (PDF)

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines

Cancers, 2019-01, Vol.11 (1), p.114

2019

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Englisch
(189)
Deutsch
(31)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient's plasma - a prospective trial

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients – A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)

Statistical controversies in clinical research: the importance of importance

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer

2775 Peritoneal cavity: The achilles' heel for ovarian cancer

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity

134 Correlation of circular RNA abundance with proliferation – exemplified with human normal, benign and malignant tissues

799: Role of cyclosporine A as chemomodulator of cisplatin cytotoxicity in ovarian cancer cell lines

eNOSI4 and EPHX1 polymorphisms affect maternal susceptibility to preeclampsia: analysis of five polymorphisms predisposing to cardiovascular disease in 279 Caucasian and 241 African women

2777 Lavage of the uterine cavity for early and differential diagnosis of serous ovarian cancer

454 Circulating rare cells enable highly efficient cancer detection

6P CHEMOTHERAPY-ENFORCED EXPRESSION OF CANCER STEM CELL MARKERS IN A SERIES OF THREE SCLC CELL LINES OBTAINED DURING CLINICAL TREATMENT

In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway

Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors : Definition of phenotypic groups

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients

Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain

Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors

Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan

Patient satisfaction after breast cancer surgery – a prospective clinical trial

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines

Suchergebnisse filtern